STOCK TITAN

Paragon 28 to Present at the CG 2024 Musculoskeletal Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Paragon 28, Inc. (NYSE: FNA) will have its Chairman and CEO, Albert DaCosta, and CFO, Steve Deitsch, participate in a fireside chat at the CG 2024 Musculoskeletal Conference. The event will take place on February 12, 2024, at 1:00 p.m. PT / 2:00 p.m. MT. A live webcast and archived recording will be accessible on the company's investor relations website.
Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the CG 2024 Musculoskeletal Conference on Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.

A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Matt Brinckman

Senior Vice President, Strategy and Investor Relations

(720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

The fireside chat is scheduled for Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.

Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be participating in the fireside chat.

The live webcast and archived recording will be available on the investor relations section of the company's website at ir.paragon28.com.
Paragon 28 Inc

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Englewood

About FNA

paragon 28 was established in 2010 as an orthopedic foot and ankle company. the name “paragon 28” was chosen to show that we are exclusively a foot and ankle company, with the “28” representing the number of bones in the foot. we will remain true to that vision. paragon 28 was started as a small, family-based company and we have kept those core ideals as we have grown. our mission is to strategically build a company around the core principles that drive innovation and quality. relentlessly working to advance the science behind foot and ankle surgery, paragon 28 is passionate about and committed to: - creation and innovation: blending different surgical philosophies from various global thought leaders to develop bio-mechanically and clinically relevant surgical solutions. - a focus on service: a customer service based, dedicated, and highly trained distribution network to the foot and ankle market. - efficient practices: meeting the needs of increasing pricing pressures and reimbursemen